Cargando…
ImmReg: the regulon atlas of immune-related pathways across cancer types
Immune system gene regulation perturbation has been found to be a major cause of the development of various types of cancer. Numbers of mechanisms contribute to gene expression regulation, thus, systematically identification of potential regulons of immune-related pathways is critical to cancer immu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643631/ https://www.ncbi.nlm.nih.gov/pubmed/34755873 http://dx.doi.org/10.1093/nar/gkab1041 |
_version_ | 1784609897533407232 |
---|---|
author | Jiang, Tiantongfei Zhou, Weiwei Chang, Zhenghong Zou, Haozhe Bai, Jing Sun, Qisen Pan, Tao Xu, Juan Li, Yongsheng Li, Xia |
author_facet | Jiang, Tiantongfei Zhou, Weiwei Chang, Zhenghong Zou, Haozhe Bai, Jing Sun, Qisen Pan, Tao Xu, Juan Li, Yongsheng Li, Xia |
author_sort | Jiang, Tiantongfei |
collection | PubMed |
description | Immune system gene regulation perturbation has been found to be a major cause of the development of various types of cancer. Numbers of mechanisms contribute to gene expression regulation, thus, systematically identification of potential regulons of immune-related pathways is critical to cancer immunotherapy. Here, we comprehensively chart the landscape of transcription factors, microRNAs, RNA binding proteins and long noncoding RNAs regulation in 17 immune-related pathways across 33 cancers. The potential immunology regulons are likely to exhibit higher expressions in immune cells, show expression perturbations in cancer, and are significantly correlated with immune cell infiltrations. We also identify a panel of clinically relevant immunology regulons across cancers. Moreover, the regulon atlas of immune-related pathways helps prioritizing cancer-related genes (i.e. ETV7, miR-146a-5p, ZFP36 and HCP5). We further identified two molecular subtypes of glioma (cold and hot tumour phenotypes), which were characterized by differences in immune cell infiltrations, expression of checkpoints, and prognosis. Finally, we developed a user-friendly resource, ImmReg (http://bio-bigdata.hrbmu.edu.cn/ImmReg/), with multiple modules to visualize, browse, and download immunology regulation. Our study provides a comprehensive landscape of immunology regulons, which will shed light on future development of RNA-based cancer immunotherapies. |
format | Online Article Text |
id | pubmed-8643631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86436312021-12-06 ImmReg: the regulon atlas of immune-related pathways across cancer types Jiang, Tiantongfei Zhou, Weiwei Chang, Zhenghong Zou, Haozhe Bai, Jing Sun, Qisen Pan, Tao Xu, Juan Li, Yongsheng Li, Xia Nucleic Acids Res Data Resources and Analyses Immune system gene regulation perturbation has been found to be a major cause of the development of various types of cancer. Numbers of mechanisms contribute to gene expression regulation, thus, systematically identification of potential regulons of immune-related pathways is critical to cancer immunotherapy. Here, we comprehensively chart the landscape of transcription factors, microRNAs, RNA binding proteins and long noncoding RNAs regulation in 17 immune-related pathways across 33 cancers. The potential immunology regulons are likely to exhibit higher expressions in immune cells, show expression perturbations in cancer, and are significantly correlated with immune cell infiltrations. We also identify a panel of clinically relevant immunology regulons across cancers. Moreover, the regulon atlas of immune-related pathways helps prioritizing cancer-related genes (i.e. ETV7, miR-146a-5p, ZFP36 and HCP5). We further identified two molecular subtypes of glioma (cold and hot tumour phenotypes), which were characterized by differences in immune cell infiltrations, expression of checkpoints, and prognosis. Finally, we developed a user-friendly resource, ImmReg (http://bio-bigdata.hrbmu.edu.cn/ImmReg/), with multiple modules to visualize, browse, and download immunology regulation. Our study provides a comprehensive landscape of immunology regulons, which will shed light on future development of RNA-based cancer immunotherapies. Oxford University Press 2021-11-10 /pmc/articles/PMC8643631/ /pubmed/34755873 http://dx.doi.org/10.1093/nar/gkab1041 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Data Resources and Analyses Jiang, Tiantongfei Zhou, Weiwei Chang, Zhenghong Zou, Haozhe Bai, Jing Sun, Qisen Pan, Tao Xu, Juan Li, Yongsheng Li, Xia ImmReg: the regulon atlas of immune-related pathways across cancer types |
title | ImmReg: the regulon atlas of immune-related pathways across cancer types |
title_full | ImmReg: the regulon atlas of immune-related pathways across cancer types |
title_fullStr | ImmReg: the regulon atlas of immune-related pathways across cancer types |
title_full_unstemmed | ImmReg: the regulon atlas of immune-related pathways across cancer types |
title_short | ImmReg: the regulon atlas of immune-related pathways across cancer types |
title_sort | immreg: the regulon atlas of immune-related pathways across cancer types |
topic | Data Resources and Analyses |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643631/ https://www.ncbi.nlm.nih.gov/pubmed/34755873 http://dx.doi.org/10.1093/nar/gkab1041 |
work_keys_str_mv | AT jiangtiantongfei immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes AT zhouweiwei immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes AT changzhenghong immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes AT zouhaozhe immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes AT baijing immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes AT sunqisen immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes AT pantao immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes AT xujuan immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes AT liyongsheng immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes AT lixia immregtheregulonatlasofimmunerelatedpathwaysacrosscancertypes |